Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1224 participants.
Also called NCT06269432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,224 participants
- Registry
-
NCT06269432
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06269432. Randomized; single masking; primary purpose prevention. Start 2023-01-01 (actual); primary completion 2024-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)
- Acronym
- PATH-STROKE
- Condition
- Ischemic Stroke
- Condition
- Antiplatelet Drug
- Intervention (Drug)
- Precision Antiplatelet Therapy Trial Group
- Intervention (Drug)
- Traditional Antiplatelet Therapy Control Group
- Lead sponsor
- Sichuan Provincial People's Hospital
Record details
- Record id
cardio:ct-nct06269432- Content hash
d1ae49f0d0055fdb8bbe38ce2aa4b425ab1614621f2064753971b9dd85c9536f